CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 254 filers reported holding CLOVIS ONCOLOGY INC in Q4 2017. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $20,016,000 | +4.3% | 806,465 | +23.4% | 0.15% | +12.6% |
| Q3 2018 | $19,198,000 | -47.4% | 653,658 | -18.5% | 0.14% | -50.4% |
| Q2 2018 | $36,470,000 | +25.5% | 802,068 | +45.7% | 0.27% | +21.4% |
| Q1 2018 | $29,057,000 | -15.5% | 550,315 | +8.9% | 0.22% | -14.8% |
| Q4 2017 | $34,378,000 | -9.2% | 505,555 | +10.0% | 0.26% | -9.6% |
| Q3 2017 | $37,860,000 | +28.3% | 459,470 | +45.8% | 0.29% | +15.5% |
| Q2 2017 | $29,509,000 | +23.4% | 315,170 | -16.1% | 0.25% | +22.9% |
| Q1 2017 | $23,910,000 | +25.4% | 375,530 | -12.5% | 0.20% | +22.8% |
| Q4 2016 | $19,064,000 | +185.6% | 429,185 | +23.4% | 0.17% | +227.5% |
| Q1 2016 | $6,675,000 | – | 347,660 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |